Scott Henry
Stock Analyst at Alliance Global Partners
(1.27)
# 3,627
Out of 5,072 analysts
51
Total ratings
37.74%
Success rate
-5.24%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.13 | +165.49% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.41 | +165.96% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $2.27 | +164.32% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.43 | +191.55% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.74 | +273.03% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $8.08 | +5.20% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.92 | +336.01% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $2.82 | +431.91% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.56 | +2,033.33% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.50 | +15.38% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.70 | +34.02% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $36.81 | -34.80% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $23.41 | -33.79% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $83.29 | -30.36% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $93.22 | -61.38% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.96 | +1,045.71% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.14 | +44.93% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $1.33 | +432,230.83% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.85 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.89 | +689.53% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $15.97 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.09 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.13
Upside: +165.49%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.41
Upside: +165.96%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $2.27
Upside: +164.32%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.43
Upside: +191.55%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.74
Upside: +273.03%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $8.08
Upside: +5.20%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.92
Upside: +336.01%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $2.82
Upside: +431.91%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.56
Upside: +2,033.33%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.50
Upside: +15.38%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $9.70
Upside: +34.02%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $36.81
Upside: -34.80%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $23.41
Upside: -33.79%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $83.29
Upside: -30.36%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $93.22
Upside: -61.38%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $0.96
Upside: +1,045.71%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.14
Upside: +44.93%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $1.33
Upside: +432,230.83%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.85
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.89
Upside: +689.53%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $15.97
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.09
Upside: -